Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Lundbeck

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Lundbeck's 2013 CNS (central nervous system) sales performance.

Global burden of depression

by Clark Health Communications for Lundbeck UK Ltd. ... Care, Consistency, Context and Control: Communicating the results of UK health technology appraisals for Selincro - by Clark Health Communications for Lundbeck UK Ltd.

Hepatitis C coverage for Gilead 2014

by Clark Health Communications for Lundbeck UK Ltd. ... Care, Consistency, Context and Control: Communicating the results of UK health technology appraisals for Selincro - by Clark Health Communications for Lundbeck UK Ltd.

Putting neurology on the map: patient groups and industry working together

by Ogilvy HealthPR for H. Lundbeck A/S. ... Lundbeck A/S. Category Sponsors.

Creating a paradigm shift in cardiology – breaking barriers for a “Cinderella Syndrome”

by Clark Health Communications for Lundbeck UK Ltd. ... Care, Consistency, Context and Control: Communicating the results of UK health technology appraisals for Selincro - by Clark Health Communications for Lundbeck UK Ltd.

Teva drug shows promise in movement disorder

Teva drug shows promise in movement disorder While there is no FDA-approved drug for TD, the drug from which Teva's candidate is derived - Lundbeck's Xenazine (tetrabenazine) - has been used off-label to treat symptoms but ... Lundbeck data in its dossier and could mean deutetrabenazine reaches the

[ Previous 5 results ] 14 15 16 17 18 19 20 21 22 23 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics